Overview

Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The overall hypothesis of this application is that the improvement in LV ejection performance following treatment with betablockers is due, at least in part, to improvement in intrinsic myocardial contractility.
Phase:
Phase 4
Details
Lead Sponsor:
Michael Debakey Veterans Affairs Medical Center
Michael E. DeBakey VA Medical Center
Treatments:
Adrenergic beta-Antagonists
Carvedilol